Baker & McKenzie and Slaughter and May have lined up to advise on the $660m (£420m) sale of 17 healthcare brands, including Gaviscon, by pharmaceutical giant GlaxoSmithKline (GSK).

Bakers has advised consumer products group Prestige Brands, which acquired the products, led by Chicago M&A partner Dieter Schmitz and London M&A partner Jane Hobson, alongside Chicago partners Edward Harrison (corporate) and Chris Bartoli (securities).